Coagulation, fibrinolysis and angiogenesis: New insights from knockout mice

被引:14
作者
Brodsky, SV [1 ]
机构
[1] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
来源
EXPERIMENTAL NEPHROLOGY | 2002年 / 10卷 / 5-6期
关键词
coagulation system; plasminogen system; enclothelial cells; angiogenesis;
D O I
10.1159/000065305
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Angiogenesis plays a key role in a broad array of physiologic and pathologic processes. Two major systems coagulation and fibrinolysis - maintaining hemostasis, have recently been implicated in angiogenesis. Generation of mice deficient in components of coagulation and plasminogen systems has provided an extraordinary opportunity to define the role of each of these systems in vivo and to elucidate molecular mechanisms involved in angiogenesis. It appears that several factors of the coagulation system, such as the tissue factor, the factor V and the thrombin receptor, play an important role in embryonic vessel formation, most probably in the formation of the primitive vascular wall. In addition, the plasminogen system appears to play a significant role in angiogenesis in adulthood, regulating the migration of endothelial and smooth muscle cells, the degradation of the extracellular matrix and activity of the metalloproteinase system. These new revelations open a possibility for future therapeutic strategies to specifically control angiogenesis in different pathological processes where abnormalities of tissue vascularization are pathogenetically prominent. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 52 条
[21]  
Frandsen TL, 2001, CANCER RES, V61, P532
[22]  
Grandaliano G, 1998, J AM SOC NEPHROL, V9, P583
[23]   A role of thrombin receptor signaling in endothelial cells during embryonic development [J].
Griffin, CT ;
Srinivasan, Y ;
Zheng, YW ;
Huang, W ;
Coughlin, SR .
SCIENCE, 2001, 293 (5535) :1666-1670
[24]  
Griffioen AW, 2000, PHARMACOL REV, V52, P237
[25]   Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy [J].
Hattenbach, LO ;
Allers, A ;
Gümbel, HOC ;
Scharrer, I ;
Koch, FHJ .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1999, 19 (05) :383-389
[26]   Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins [J].
Hiraoka, N ;
Allen, E ;
Apel, IJ ;
Gyetko, MR ;
Weiss, SJ .
CELL, 1998, 95 (03) :365-377
[27]  
Huang YQ, 2001, THROMB HAEMOSTASIS, V86, P1094
[28]  
Isermann B, 2001, DEVELOPMENT, V128, P827
[29]   Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy [J].
Kimura, H ;
Gejyo, F ;
Suzuki, Y ;
Suzuki, S ;
Miyazaki, R ;
Arakawa, M .
KIDNEY INTERNATIONAL, 1998, 54 (05) :1659-1669
[30]  
Levi M, 2001, CIRCULATION, V103, P2014